Immuno-Oncology Program

Product ID : IOP
Price: $175.00
You will receive a link to your product from within 1 hour of purchase confirmation. Shipping charges do not apply to digital products.
E-mail to a friend



Breakthroughs in immuno-oncology are showing great potential to revolutionize cancer treatment, but keeping up-to-date with new testing protocols, diagnoses, and therapeutic treatments is challenging for many pathologists and laboratory professionals. This program is designed to help the busy clinician keep on top of the rapidly developing field of immunotherapy as it relates to the field of oncology. The program address a wide variety of topics including cancer immunobiology, classes of agents, potential predictive biomarkers, clinical activity in the areas of melanoma and non-small cell lung cancer, response determination and the management of immune-related adverse events.

At the end of this course, users should be able to:

1) Describe the components of the normal human immune system and their role in surveillance and anti-tumor activity

2) Identify the mechanisms by which cancer vaccines may induce specific immunity to cancer

3) Examine other potential biomarkers of benefit to immune checkpoint blockade

4) Identify the immune modulating agents that have been used in the clinic

5) Apply RECIST-based response assessments to patients receiving cancer immunotherapy in the clinic, and

6) Describe management strategies for the toxicities associated with immunotherapies.

IMPORTANT NOTE: The Immuno-Oncology Program expires on May 18, 2020. Users must complete all necessary course components by this date to be eligible to claim MOC and CME credit.